Hemispherx Extends Alliance With Armada Health Care For Alferon N Injection

(RTTNews) - Hemispherx Biopharma Inc. (HEB) announced that as the Company works toward the re-launch of Alferon N, it has extended its agreement with Armada Health Care, LLC for two years (through August 14 2017) for the sales/marketing of Alferon N Injection, its Food and Drug Administration approved natural interferon, in the U.S.

As per the Agreement, the Company will manufacture and supply Alferon N Injection to physicians and patients through Armada's national network of specialty pharmacies.

Armada has agreed to provide ongoing sales and marketing to support the product's re-launch. Specialty Distributor, BioRidge Pharma, LLC , has received a two year contract extension and will warehouse, ship, and distribute Alferon N Injection® on an exclusive basis for U.S. sales.